Department of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts.
Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
JAMA Oncol. 2020 Dec 1;6(12):e204759. doi: 10.1001/jamaoncol.2020.4759. Epub 2020 Dec 10.
Serious illness conversations (SICs) are structured conversations between clinicians and patients about prognosis, treatment goals, and end-of-life preferences. Interventions that increase the rate of SICs between oncology clinicians and patients may improve goal-concordant care and patient outcomes.
To determine the effect of a clinician-directed intervention integrating machine learning mortality predictions with behavioral nudges on motivating clinician-patient SICs.
DESIGN, SETTING, AND PARTICIPANTS: This stepped-wedge cluster randomized clinical trial was conducted across 20 weeks (from June 17 to November 1, 2019) at 9 medical oncology clinics (8 subspecialty oncology and 1 general oncology clinics) within a large academic health system in Pennsylvania. Clinicians at the 2 smallest subspecialty clinics were grouped together, resulting in 8 clinic groups randomly assigned to the 4 intervention wedge periods. Included participants in the intention-to-treat analyses were 78 oncology clinicians who received SIC training and their patients (N = 14 607) who had an outpatient oncology encounter during the study period.
(1) Weekly emails to oncology clinicians with SIC performance feedback and peer comparisons; (2) a list of up to 6 high-risk patients (≥10% predicted risk of 180-day mortality) scheduled for the next week, estimated using a validated machine learning algorithm; and (3) opt-out text message prompts to clinicians on the patient's appointment day to consider an SIC. Clinicians in the control group received usual care consisting of weekly emails with cumulative SIC performance.
Percentage of patient encounters with an SIC in the intervention group vs the usual care (control) group.
The sample consisted of 78 clinicians and 14 607 patients. The mean (SD) age of patients was 61.9 (14.2) years, 53.7% were female, and 70.4% were White. For all encounters, SICs were conducted among 1.3% in the control group and 4.6% in the intervention group, a significant difference (adjusted difference in percentage points, 3.3; 95% CI, 2.3-4.5; P < .001). Among 4124 high-risk patient encounters, SICs were conducted among 3.6% in the control group and 15.2% in the intervention group, a significant difference (adjusted difference in percentage points, 11.6; 95% CI, 8.2-12.5; P < .001).
In this stepped-wedge cluster randomized clinical trial, an intervention that delivered machine learning mortality predictions with behavioral nudges to oncology clinicians significantly increased the rate of SICs among all patients and among patients with high mortality risk who were targeted by the intervention. Behavioral nudges combined with machine learning mortality predictions can positively influence clinician behavior and may be applied more broadly to improve care near the end of life.
ClinicalTrials.gov Identifier: NCT03984773.
严重疾病对话(SICs)是临床医生和患者之间关于预后、治疗目标和临终偏好的结构化对话。增加肿瘤科临床医生和患者之间 SICs 发生率的干预措施可能会改善目标一致的护理和患者结局。
确定一种临床医生指导的干预措施,该措施将机器学习死亡率预测与行为提示相结合,以激发临床医生与患者进行 SICs。
设计、设置和参与者:这是一项在宾夕法尼亚州的一个大型学术医疗系统内的 9 个医学肿瘤学诊所(8 个肿瘤亚专科和 1 个普通肿瘤学诊所)进行的 20 周(从 2019 年 6 月 17 日至 11 月 1 日)的分步楔形群随机临床试验。两个最小的肿瘤亚专科诊所的临床医生被分为一组,结果有 8 个诊所组被随机分配到 4 个干预楔形期。意向治疗分析包括 78 名接受 SIC 培训的肿瘤学临床医生及其患者(N=14607),他们在研究期间有门诊肿瘤学就诊。
(1)每周向肿瘤学临床医生发送 SIC 绩效反馈和同行比较的电子邮件;(2)为下周安排最多 6 名高风险患者(≥180 天死亡率预测风险的 10%)的名单,使用经过验证的机器学习算法进行估计;(3)在患者预约日向临床医生发送退出文本消息提示,以考虑进行 SIC。对照组的临床医生接受常规护理,包括每周发送包含累积 SIC 绩效的电子邮件。
干预组与常规护理(对照组)组中患者就诊时进行 SIC 的百分比。
该样本包括 78 名临床医生和 14607 名患者。患者的平均(SD)年龄为 61.9(14.2)岁,53.7%为女性,70.4%为白人。在所有就诊中,对照组中有 1.3%进行了 SIC,干预组中有 4.6%进行了 SIC,差异显著(调整后的百分比差异,3.3;95%CI,2.3-4.5;P<0.001)。在 4124 例高危患者就诊中,对照组中有 3.6%进行了 SIC,干预组中有 15.2%进行了 SIC,差异显著(调整后的百分比差异,11.6;95%CI,8.2-12.5;P<0.001)。
在这项分步楔形群随机临床试验中,向肿瘤学临床医生提供机器学习死亡率预测和行为提示的干预措施显著提高了所有患者以及接受干预的高死亡率风险患者进行 SIC 的比例。行为提示与机器学习死亡率预测相结合可以积极影响临床医生的行为,并可能更广泛地应用于改善临终关怀。
ClinicalTrials.gov 标识符:NCT03984773。